Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Response to the Cures 2.0 Request for Information
-
ACMG Response to PLUGS on Framework for Development of Payer Medical Necessity Policy
-
Sign-on Letter Opposing the Patent Eligibility Restoraction Act of 2024
-
ACMG Response to RFI on Gene Therapies Access for Rare Diseases
-
ACMG & ABMGG Joint Response to Supreme Court Ruling on Affirmative Action
-
ACMG Response to NYS on Proposed Changes to Onsite Work Requirements for Lab Directors
-
ACMG Comment to NCD on Germline Editing and Impact on People with Disabilities
-
Sign-on Letter Opposing Cigna Policy on Use of Modifier -25